GPR35-KLF5 Circuitry in Epithelial Repair During DSS Colitis

Study Background and Research Question

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurring episodes of intestinal mucosal damage and impaired barrier function, presenting challenges for both mechanistic research and therapeutic development (reference_paper). The colonic epithelium, specifically the intestinal epithelial cells (IECs), plays a central role in both barrier integrity and the coordination of injury response. While the importance of IEC proliferation and migration in mucosal repair is well-established, the precise molecular mechanism by which IECs sense mucosal injury and initiate repair programming has remained elusive. A major knowledge gap has existed around how metabolic cues and receptor signaling converge to trigger epithelial regeneration following chemically induced colitis, such as that modeled by dextran sulfate sodium salt (DSS; MW 35000-45000) administration (internal_review).

Key Innovation from the Reference Study

The reference study identifies a critical gatekeeping mechanism by which IECs detect and respond to mucosal damage signals. Specifically, the authors define a regulatory circuit in which the G protein-coupled receptor 35 (GPR35) senses metabolic shifts in the tryptophan–kynurenine–kynurenic acid (Trp–KYN–KA) axis. Upon sensing KA, GPR35 triggers a signaling cascade that activates Kruppel-like factor 5 (KLF5), a transcription factor essential for epithelial regeneration. Notably, the study demonstrates that GPR35 employs a unique "sandwich" structural mode for KA binding, which enables highly specific detection of tissue injury–associated changes in metabolic fluxes. This GPR35-KLF5 circuit orchestrates the proliferation and migration of IECs required for mucosal repair, integrating metabolic and transcriptional control in a single surveillance module (reference_paper).

Methods and Experimental Design Insights

The study utilizes murine models of colitis, induced by oral administration of DSS (MW 35000-45000), to mimic the pathophysiology of human UC. The DSS-induced mouse model is a well-established system that recapitulates key features of intestinal inflammation, barrier disruption, and epithelial injury (internal_mechanistic). The authors employ a combination of genetic, biochemical, and histological assays to dissect the roles of GPR35 and KLF5. Knockout and overexpression models are used to manipulate GPR35 and KLF5 expression in IECs, while targeted metabolomics quantify Trp–KYN–KA axis intermediates. Structural modeling and ligand–receptor binding assays define the unique KA binding mode of GPR35. Downstream signaling is assessed through analyses of PI3K-AKT-mTOR pathway activation, and epithelial repair is evaluated by quantifying IEC proliferation, migration, and restitution after DSS challenge (reference_paper).

Protocol Parameters

• chemical inducer of experimental colitis (DSS) | 2.5–5% (w/w) in drinking water | mouse model of inflammatory bowel disease | Standard concentration range induces reproducible colonic epithelial apoptosis and mucosal barrier disruption in C57BL/6 mice | internal_guidance
• treatment duration | 5–7 days | acute colitis induction in mice | Balances effective epithelial injury with animal welfare; longer duration models chronicity | internal_mechanistic
• genetic manipulation (e.g., GPR35 knockout) | validated murine lines | applicability to repair circuit dissection | Enables causal testing of GPR35-KLF5 axis in vivo | reference_paper
• IEC proliferation/migration assays | EdU incorporation, wound restitution | quantifies repair response | Direct readouts for functional regeneration after DSS injury | workflow_recommendation

Core Findings and Why They Matter

The central finding is that GPR35 acts as a metabolic biosensor, translating changes in tryptophan catabolism (particularly the accumulation of KA) into a transcriptional repair program via KLF5. Mechanistically, KA binding to GPR35 induces PI3K-AKT-mTOR signaling, leading to upregulation of KLF5-dependent gene networks essential for IEC proliferation and migration. Disruption of either KA sensing (GPR35 deficiency) or downstream signaling (KLF5 knockout) impairs mucosal repair following DSS-induced colitis, resulting in persistent barrier defects and exacerbated tissue injury (reference_paper). These results clarify a previously opaque step in epithelial damage sensing, directly linking metabolic surveillance to regenerative responses. The findings are significant for UC research because they highlight actionable molecular targets for modulating mucosal repair, and provide a framework for investigating why some patients develop chronic, non-healing colitis (internal_repair).

Comparison with Existing Internal Articles

Several recent reviews and expert perspectives have discussed the importance of DSS (MW 35000-45000) as a chemical inducer of colitis and a platform for mechanistic studies in IBD (internal_guidance). For instance, the article "GPR35-KLF5 Circuitry Orchestrates Epithelial Repair in DSS Colitis" summarizes the mechanistic insights into how metabolic sensing pathways govern epithelial restitution in DSS models. Meanwhile, "Dextran Sulfate Sodium Salt (MW 35000-45000): Mechanistic..." contextualizes APExBIO’s DSS in the landscape of IBD modeling and discusses its utility for dissecting repair mechanisms. The present reference study goes beyond correlative observation by delineating the specific GPR35-KLF5 axis and demonstrating causality in pathway function. It also leverages advanced structural and metabolic assays not previously integrated in internal reviews, offering a more granular view of the damage-sensing and repair initiation process.

Limitations and Transferability

Despite its mechanistic depth, the study’s conclusions are primarily based on murine models and genetic manipulation of IEC-specific pathways. While the DSS-induced mouse model recapitulates many features of human UC, species differences in tryptophan metabolism and GPR35 expression may limit direct clinical translation. Furthermore, the experiments were conducted under controlled laboratory conditions; effects in the context of human microbiota variability, comorbidities, or long-term colitis remain to be investigated (internal_repair). The study does not address the potential impact of other metabolic or immune pathways that may interact with the GPR35-KLF5 axis. As with all reductionist models, caution is warranted in extrapolating results to human disease without further validation.

Research Support Resources

To reproduce or extend the findings of this study, researchers should employ rigorously specified DSS (MW 35000-45000) for chemical induction of experimental colitis. Dextran sulfate sodium salt (MW 35000-45000) (SKU B8205, APExBIO) is widely used for modeling acute and chronic intestinal inflammation in preclinical settings, supporting investigations into epithelial damage sensing and repair (internal_guidance). Its defined polyanionic structure and validated performance facilitate reproducible induction of colonic epithelial injury, enabling high-fidelity studies of pathways such as the GPR35-KLF5 circuit. For detailed protocols and mechanistic rationale, consult both the reference study and recent internal reviews.